Abstract:Type 1 diabetes (T1D) is an autoimmune disease resulting from T cell-mediated β cell destruction in the pancreas of genetically susceptible individuals. Extensive familial and population genetic studies uncovered the strong linkage and association between HLA gene variants and T1D. Non-HLA genes have also been associated with T1D, such as INS, CTLA4, and PTPN22. T1D is considered as one of the most heritable common diseases. However, evidence that monozygotic twins have incomplete concordance of disease susceptibility provides convincing proof that environmental factors also play important roles in the pathogenesis of the disease. Environmental factors can induce the alterations of gene expression via epigenetic mechanisms. Epigenetic modifications refer to the alterations in gene expression without changes of the DNA sequence, but instead occur as a result of DNA methylation, histone modifications, and miRNA regulation. Aberrant epigenetic modifications will cause the dysregulation of gene expression, thus leading to a variety of human diseases. There are significant differences in DNA methylation, histone modifications, and miRNA profiling found in T1D patients compared with healthy individuals. Epigenetic modifications contribute to the pathogenesis of T1D mainly by regulating the expression of susceptible genes in T1D. These susceptible genes are involved in antigen presentation (such as HLA), immune tolerance (such as FOXP3 and CTLA4), autoreactive T cell response (such as GAD65), and β cell functions (such as INS). A better understanding of epigenetic mechanisms for regulating susceptible genes of T1D will help identify candidates that target epigenetic pathways to control and/or prevent T1D. Knowledge of epigenetic changes in T1D also provides us with potential biomarkers for diagnosis, prognostication, personalized treatment, and prevention of the disease.

Deficiency of Trex1 leads to spontaneous development of type 1 diabetes

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

IL-10 Deficiency Accelerates Type 1 Diabetes Development via Modulation of Innate and Adaptive Immune Cells and Gut Microbiota in BDC2.5 NOD Mice

GPR41 deficiency aggravates type 1 diabetes in streptozotocin-treated mice by promoting dendritic cell maturation

TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model

Type-1 interferon induced cross-regulation of IL-10 function: a novel mechanism in type 1 diabetes development

Biological function of type 1 regulatory cells and their role in type 1 diabetes

Islet‐Resident Memory T Cells Orchestrate the Immunopathogenesis of Type 1 Diabetes through the FABP4‐CXCL10 Axis

Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis

The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes

Progress in the Relationship between Vitamin D Deficiency and the Incidence of Type 1 Diabetes Mellitus in Children

Toll-like Receptor 9 Negatively Regulates Pancreatic Islet Beta Cell Growth and Function in a Mouse Model of Type 1 Diabetes

The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus

Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes

Research progress on immunology of type 1 diabetes mellitus

Regulatory T Cells and Type 1 Diabetes

Beyond Genetics: What Causes Type 1 Diabetes

Early senescence of pancreatic β cells induced by unfolded protein response deficiency prevents type 1 diabetes

Innate Immunity in Type 1 Diabetes

NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets

TLR5-deficiency controls dendritic cell subset development in an autoimmune diabetes-susceptible model